These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 30170358)
1. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma. Dang S; Zhou J; Wang Z; Wang K; Dai S; He S Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5. Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968 [TBL] [Abstract][Full Text] [Related]
3. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT. Wang Y; Yang Z; Wang L; Sun L; Liu Z; Li Q; Yao B; Chen T; Wang C; Yang W; Liu Q; Han S Biomed Pharmacother; 2019 Jan; 109():991-999. PubMed ID: 30551553 [TBL] [Abstract][Full Text] [Related]
4. miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19. Yao X; Zhang H; Liu Y; Liu X; Wang X; Sun X; Cheng Y Gene; 2019 May; 698():141-149. PubMed ID: 30849536 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma. Tang SJ; Yang JB Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866 [TBL] [Abstract][Full Text] [Related]
7. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208 [TBL] [Abstract][Full Text] [Related]
8. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells. Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration. Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
11. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway. Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734 [TBL] [Abstract][Full Text] [Related]
12. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS. Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462 [TBL] [Abstract][Full Text] [Related]
13. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3. Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005 [TBL] [Abstract][Full Text] [Related]
15. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1. Ying J; Yu X; Ma C; Zhang Y; Dong J Mol Med Rep; 2017 Aug; 16(2):1603-1611. PubMed ID: 28627662 [TBL] [Abstract][Full Text] [Related]
17. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Shi Y; Yan F; Wang F; Pan L Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762 [TBL] [Abstract][Full Text] [Related]
18. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1. Li Y; Bai W; Zhang J Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
20. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma. Zhao X; Chen GQ; Cao GM Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]